Mar 3, 2026 09:30AM
Feb 24, 2026 10:17AM
Feb 24, 2026 07:00AM
Feb 24, 2026 07:00AM
Jan 5, 2026 06:20AM
Nov 5, 2025 07:00AM
Sep 30, 2025 04:05AM Citizens JMP Reiterates Market Outperform Rating on Larimar Therapeutics (LRMR)
Sep 29, 2025 07:02AM
Sep 29, 2025 07:00AM
Sep 28, 2025 05:00PM
Sep 16, 2025 06:51AM
Aug 19, 2025 04:12AM
Aug 14, 2025 02:19PM
Aug 14, 2025 07:00AM Larimar Therapeutics Reports Second Quarter 2025 Financial Results
Jul 8, 2025 07:02AM
Jul 8, 2025 07:00AM
Jun 25, 2025 06:07AM
Jun 23, 2025 01:29PM
Jun 23, 2025 08:27AM
Jun 23, 2025 07:01AM
Jun 23, 2025 07:00AM Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich’s Ataxia Program
Jun 20, 2025 04:05PM
Apr 30, 2025 07:00AM
Apr 23, 2025 04:21AM
Mar 25, 2025 12:52PM
Mar 25, 2025 06:49AM
Mar 25, 2025 04:24AM
Mar 24, 2025 07:01AM Larimar Therapeutics (LRMR) Provides Nomlabofusp Development Update
Mar 24, 2025 07:00AM
Jan 24, 2025 05:18AM
Jan 23, 2025 04:05PM
Dec 17, 2024 06:53AM
Dec 16, 2024 02:38PM
Dec 16, 2024 02:23PM
Dec 16, 2024 01:55PM Guggenheim Reiterates Buy Rating on Larimar Therapeutics (LRMR)
Dec 16, 2024 07:02AM
Dec 16, 2024 07:00AM
Nov 19, 2024 06:56AM
Nov 18, 2024 07:02AM
Nov 18, 2024 07:00AM
Oct 30, 2024 07:00AM
Oct 3, 2024 06:48AM Wedbush Starts Larimar Therapeutics (LRMR) at Outperform
Sep 19, 2024 07:00AM
Sep 4, 2024 06:27AM
Aug 7, 2024 07:00AM
May 30, 2024 04:13PM
May 30, 2024 04:05PM
May 20, 2024 05:00PM
May 20, 2024 04:08PM Larimar Therapeutics (LRMR) Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program
May 20, 2024 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All